Chemerin treatment enhances migration and invasion of ovarian carcinoma cell lines by activation of chem1 leading to epithelial to mesenchymal transition (EMT) in cell culture experiments [71]. This evidence concerns the gene RARRES2 and ovarian carcinoma.